Fliban 100 mg Tablet

Description

Fliban 100 mg Tablet contains flibanserin, a first-of-its-kind prescription medicine that supports female sexual wellness by treating a specific condition known as hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD is characterized by persistently low sexual desire that causes significant emotional distress or strain in relationships, not explained by medical, psychological, or lifestyle factors. Unlike hormonal treatments, flibanserin works on brain chemicals involved in sexual desire and mood, particularly increasing dopamine and norepinephrine while reducing serotonin. This helps restore a healthy sexual desire pattern. Taken once daily at bedtime, Fliban offers a discreet, non-hormonal option for improving sexual health and well-being in women. Important Note: Fliban is not meant for enhancing sexual performance or treating low libido due to external factors such a

Benefits

• Clinically Proven to Improve Sexual Desire: Flibanserin—the active ingredient in Fliban 100 mg—is the first FDA-approved medication for Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. In clinical trials, women taking flibanserin reported a significant increase in sexual desire scores and the number of satisfying sexual events per month compared to placebo.
  
• Reduces Distress Related to Low Libido: Low sexual desire in HSDD is often associated with emotional stress, frustration, or relationship tension. Flibanserin may help relieve psychological burden and improve emotional well-being by supporting a healthier libido.
• Convenient Once-Daily Dosing: Fliban is taken once daily at bedtime, offering a simple routine with steady, long-term benefits. Nighttime dosing helps reduce the risks of dizziness or fainting.
• Non-Hormonal Mechanism of Action: Unlike treatments based on estrogen or testosterone, flibanserin does not alter hormone levels. Instead, it works on neurotransmitters in the brain, enhancing desire by rebalancing serotonin, dopamine, and norepinephrine.
  

Indications and Usage

Fliban 100 mg Tablet is specifically indicated for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. HSDD is recognized as a genuine and diagnosable sexual health disorder. Fliban is not intended for use in men, postmenopausal women, or for enhancing sexual performance in individuals without HSDD.

Clinical guidelines recommend using Fliban only after ruling out other possible causes of low libido (such as depression, medication side effects, or hormone imbalance). Its use should be guided by a healthcare professional.

It is not for use in:

• Postmenopausal women
• Men
• Women with low libido due to other causes (e.g., stress, relationship problems, medical conditions)

How it Works

Flibanserin acts on the brain’s neurochemical pathways that regulate sexual desire. It is not a hormone but a centrally acting compound that helps balance the brain signals linked to sexual interest.

Neurotransmitter Action:

• Lowers Serotonin: High serotonin levels in specific brain areas can suppress sexual desire. Flibanserin reduces serotonin activity, helping lift this inhibitory effect.
• Boosts Dopamine and Norepinephrine: These neurotransmitters are critical in motivation, reward, and sexual arousal. By increasing their levels, flibanserin helps rekindle interest in sexual activity.

This rebalancing improves the brain’s natural response to sexual cues, which is often disrupted in women with HSDD. Unlike antidepressants that usually dampen libido, flibanserin is designed to restore it—essentially “resetting the brain’s desire thermostat.

Dosage & Administration

• Recommended Dose: One 100 mg tablet taken orally at bedtime every day.
• Why Bedtime Dosing? Flibanserin can cause drowsiness, dizziness, low blood pressure, or fainting, especially during waking hours. Taking it at bedtime helps minimize these risks.
• Missed Dose Instructions: If a dose is missed, skip it and resume the next night. Do not double up—this increases the risk of side effects.
• How Long Before Results?
  Flibanserin is not a “quick fix”. It may take 4 to 8 weeks of daily use to notice meaningful improvements in desire and emotional well-being. If no benefit is seen after 8 weeks, your doctor may advise discontinuing treatment.
• Important Tip: Always take Fliban exactly as prescribed and never with alcohol or certain medications (e.g., CYP3A4 inhibitors) without medical supervision.

Strengths & Substitutes

Common Substitutes:

• Addyi 100 mg (brand version)
  
• Generic flibanserin tablets

Substitution should only be done under a healthcare provider’s guidance.

Side Effects

Common Side Effects of Fliban Flibanserin 100 mg: 

• Dizziness or lightheadedness
• Sleepiness or fatigue
• Nausea
• Dry mouth
• Difficulty sleeping

Less Common but Serious:

• Low blood pressure
• Fainting or blackouts, especially if combined with alcohol or certain medicines
• Severe sleepiness during daily activities

Stop use and call your doctor if you faint, feel extremely tired, or experience chest pain.

Warning and Precaution

• Avoid Alcohol: Drinking alcohol can significantly increase the risk of fainting or low blood pressure.
• Do Not Drive or Operate Machinery after taking the medicine.
• Not for Use in Pregnancy or Breastfeeding: Safety not established.

Tell your doctor if you have: liver problems, depression, heart issues, or take antidepressants or antifungals.

Patient Guidance

Storage Instructions:

• Keep in a cool, dry place, away from moisture and direct sunlight.
• Store at room temperature (20–25°C or 68–77°F).
• Keep out of reach of children and pets.

General Use Tips:

• Take at bedtime only
• Do not mix with alcohol or sedatives.
• Report any unusual symptoms to your doctor immediately

Stick with regular doctor follow-ups. This content is for informational purposes only and does not replace medical advice. Always consult your doctor before starting or stopping any medication, including Fliban 100 mg Tablet.

Clinical Trial & Approvals

Flibanserin was rigorously evaluated in more than 11,000 women through a series of placebo-controlled clinical trials. These studies targeted premenopausal women diagnosed with HSDD.

Key Outcomes:

• Women taking flibanserin experienced a statistically significant increase in:
  • The number of satisfying sexual events (SSEs) per month
  • Sexual desire scores (measured using validated scales)
  • Reduction in distress related to low libido
• Regulatory Approval:
  In August 2015, the U.S. Food and Drug Administration (FDA) approved flibanserin under Addyi, making it the first to treat HSDD in premenopausal women.
• The approval followed years of research and safety evaluation, addressing efficacy and side effect management strategies.

References

MedlinePlus – Flibanserin Oral
General drug information, uses, side effects, and precautions. Click here

Mayo Clinic – Flibanserin Oral Route
Guidance on dosage, warnings, and drug interactions. Click here

Drugs.com – Flibanserin (Addyi)
Overview, side effects, interactions, and patient safety info. Click here

NCBI – Flibanserin (StatPearls)
Detailed medical and clinical review of flibanserin and its use. Click here

DrugBank – Flibanserin (DB04908)
Pharmacological data and chemical profile. Click here

Medscape Reference – Addyi (Flibanserin)
Clinical prescribing guide and side effect profile. Click here

Cleveland Clinic – Flibanserin Oral Tablets
Patient guide on how the medicine is used and monitored.  Click here